To simplify our services for our clients, the Creapharm brand will become Myonex in 2025. This transition will not impact your current services but will streamline your experience under the unified Myonex brand.
This rebranding does not mean any changes to the French services or facilities, and will not change anything in the daily business of our clients. We will continue to combine the local strengths and expertise of the US, UK, German and French teams to offer the best services for our clients.
Clinical Trial Supply Management
Commercial Packaging
Biotherapies & ATMP Supply Chain Management
Pharma and Biotechs Served
years in industry
patient-centric experts
global locations
depots globally